Serotonin, Impulsivity, and Cocaine Dependence Treatment
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.
Full description
Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopram for cocaine dependence. The primary outcome measure is benzoylecgonine positive urines. Secondary measures of side effects and craving are also examined.
Sex
Ages
Volunteers
Inclusion criteria
- male and female subjects age 18 to 50 who currently meet DSM-IV criteria for cocaine dependence.
- female subjects: a negative pregnancy test
Exclusion criteria
- current or past DSM-IV Axis I disorder other than substance abuse/dependence
- any serious non-psychiatric medical illness requiring ongoing medical treatment
- substance dependence other than cocaine within the last 3 months
- negative urine drug screen for cocaine at time of testing
- for female subjects: a positive pregnancy test
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal